NCT03354637 - A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

April 18, 2019

Study Completion Date

September 10, 2019

Conditions

Alopecia Areata

Interventions

DRUG

ATI-50002 high dose

Topical solution

DRUG

ATI-50002 low dose

Topical solution

DRUG

Placebo

Topical solution

Trial Locations (23)

10155

Aclaris Investigator Site, New York

19034

Aclaris Investigator Site, Fort Washington

20037

Aclaris Investigator Site, Washington D.C.

27104

Aclaris Investigator Site, Winston-Salem

27710

Aclaris Investigator Site, Durham

33136

Aclaris Investigator Site, Miami

33472

Aclaris Investigator Site, Boynton Beach

37215

Aclaris Investigator Site, Nashville

37922

Aclaris Investigator Site, Knoxville

48038

Aclaris Investigator Site, Clinton Township

48088

Aclaris Investigator Site, Warren

55432

Aclaris Investigator Site, Fridley

55455

Aclaris Investigator Site, Minneapolis

68144

Aclaris Investigator Site, Omaha

78229

Aclaris Investigator Site, San Antonio

78745

Aclaris Investigator Site, Austin

Aclaris Investigator Site, San Antonio

78759

Aclaris Investigator Site, Austin

92024

Aclaris Investigator Site, Encinitas

92653

Aclaris Investigator Site, Laguna Hills

94063

Aclaris Investigator Site, Redwood City

97210

Aclaris Investigator Site, Portland

02115

Aclaris Investigator Site, Boston